期刊文献+

YMDD variants of HBV DNA polymerase gene: Rapid detection and clinicopathoiogical analysis with long-term Iamivudine therapy after liver transplantation 被引量:1

YMDD variants of HBV DNA polymerase gene: Rapid detection and clinicopathoiogical analysis with long-term Iamivudine therapy after liver transplantation
下载PDF
导出
摘要 AIM: To look for a rapid low-cost technique for the detection of HBV variants.METHODS: Two patients who underwent orthotopic liver transplantation (OLT) for HBV infection were treated with lamivudine (100 mg daily) and HBV infection recurred in the grafted livers. The patients were monitored intensively for liver enzymes, hepatitis B surface antigen (HBsAg) and HBV DNA in serum. Liver biopsy was performed regularly. HBV DNA in a conserved polymerase domain (the YMDD locus) was amplified from serum of each patient by PCR and sequenced. HBV genotypes were analyzed by restriction fragment length polymorphism (RFLP) of the PCR products generated from a fragment of the polymerase gene.RESULTS: YMDD wild-type HBV was detected in one patient by PCR-RFLP and DNA sequencing 19 mo after OLT, and YIDD mutant-type HBV in the other patient, 16 mo after OLT.CONCLUSION: PCR-RFLP assay is an accurate and simple method for genotyping lamivudine-resistant HBV variants. AIM: To look for a rapid low-cost technique for the detection of HBV variants. METHODS: Two patients who underwent orthotopic liver transplantation (OLT) for HBV infection were treated with lamivudine (100 mg daily) and HBV infection recurred in the grafted livers. The patients were monitored intensively for liver enzymes, hepatitis B surface antigen (HBsAg) and HBV DNA in serum. Liver biopsy was performed regularly. HBV DNA in a conserved polymerase domain (the YMDD locus) was amplified from serum of each patient by PCR and sequenced. HBV genotypes were analyzed by restriction fragment length polymorphism (RFLP) of the PCR products generated from a fragment of the polymerase gene. RESULTS: YMDD wild-type HBV was detected in one patient by PCR-RFLP and DNA sequencing 19 mo after OLT, and YIDD mutant-type HBV in the other patient, 16 mo after OLT. CONCLUSION: PCR-RFLP assay is an accurate and simple method for genotyping lamivudine-resistant HBV variants.
机构地区 DepartmentofPathology
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第18期2714-2719,共6页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China, No. 30170363 the Major Science and Technology Program of Ministry of Education, No. 01003 the Major State Basic Research Development Program of China, No. 2002CB513100 the National Key Technology Research and Development Program of China during the 10~(th) Five-Year Plan Period, No. 2001BA703B05
关键词 Liver transplantation HBV DNA Polymerase gene YMDD variants PCR-RFLP YMDD 病毒DNA 聚合酶基因 乙型肝炎病毒 临床病理学 肝移植
  • 相关文献

参考文献32

  • 1Hanazaki K. Antiviral therapy for chronic hepatitis B: a review. Curr Drug Targets lnflamm Allergy 2004; 3:63-70.
  • 2Lake JR, Wright TL. Liver transplantation for patients with hepatitis B: have we learned from our results? Hepatology 1991: 13:796-799.
  • 3Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS,Heathcote J. Effects of alpha-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B: a metaanalysis. Ann Intern Med 1993; 119:312-323.
  • 4Fu L, Liu SH, Cheng YC. Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues. Biochem Pharmacol 1999; 15:1351-1359.
  • 5Ling R, Mutimer D, Ahmed M, Boxall Eh, Elias E, Du-sheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 3:711-713.
  • 6Nevens F, Main J, Honkoop P, Tyrrell D1, Braber J, Sullivan M, Fevery J, De-Man RA, Thomas HC. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose ranging study. Gastroenterology 1997; 113:1258-1263.
  • 7Chan HL, Chui AK,Lau WY, Chan FK, Hui AY, Rao AR,Wong J, Lai EC, Sung JJ. Outcome of lamivudine resist anthepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis. Clin Transplant 2004; 18:295-300.
  • 8Yuen MF, Kato T, Mizokami M, Chan AO, Yuen JC, Yuan HJ,Wong DK, Sum SM, Ng IO, Fan ST, Lai CL. Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations. J Hepatol 2003; 39:850-855.
  • 9Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE. Treatment of hepatitis B reinfection after liver transplantation.Minerva Chir 2003; 58:705-716.
  • 10Ben-Ari Z, Pappo O, Zemel R, Mor E, Tur-Kaspa R. Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis. Transplantation 1999; 68:232-236.

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部